A Recent Discovery Could Make Cancer Treatments More Effective
ColiN00B / Pixabay

A Recent Discovery Could Make Cancer Treatments More Effective

According to a story from news-medical.net, scientists may have made a significant breakthrough discovery that could make cancer treatment more effective. The discovery involves a new method that breaks through…

Continue Reading A Recent Discovery Could Make Cancer Treatments More Effective
ICYMI: With the FDA’s Third Approval for Tissue Agnostic Therapies, Oncologists are Headed to the Next Level in Cancer Treatment
source: pixabay.com

ICYMI: With the FDA’s Third Approval for Tissue Agnostic Therapies, Oncologists are Headed to the Next Level in Cancer Treatment

Since the 1940s oncologists have been focusing on tumors at the location in the body where the tumors originated. According to a recent FDA press release, this is the third…

Continue Reading ICYMI: With the FDA’s Third Approval for Tissue Agnostic Therapies, Oncologists are Headed to the Next Level in Cancer Treatment
Combination Treatment for Chronic Lymphocytic Leukemia to Soon be Covered on the NHS in Scotland
FrankWinkler / Pixabay

Combination Treatment for Chronic Lymphocytic Leukemia to Soon be Covered on the NHS in Scotland

According to a story from Cancer Research UK, a combination treatment featuring the targeted cancer therapy venetoclax (marketed as Venclyxto) and the monoclonal antibody rituximab will soon be covered by…

Continue Reading Combination Treatment for Chronic Lymphocytic Leukemia to Soon be Covered on the NHS in Scotland
Large Scale Trial Aims to Test Precision Medicines Based on Genomic Profiling in a Variety of Cancers
source: pixabay.com

Large Scale Trial Aims to Test Precision Medicines Based on Genomic Profiling in a Variety of Cancers

According to a story from Newswise, Quest Diagnostics, a laboratory that specializes in diagnostic information, has announced plans to participate in a unique, large scale trial called NCI-MATCH, which stands…

Continue Reading Large Scale Trial Aims to Test Precision Medicines Based on Genomic Profiling in a Variety of Cancers

Bladder Cancer Drug That Received Accelerated Approval Shows Even Stronger Findings in Later Study

According to a publication from Medscape, the first ever drug targeted for bladder cancer has shown even more impressive results in post-approval study. Erdafitinib was approved on an accelerated basis…

Continue Reading Bladder Cancer Drug That Received Accelerated Approval Shows Even Stronger Findings in Later Study

A Brief Discussion of How Cell and Gene Therapies are Being Improved for Future Generations

  While the last few years have seen major advances in all areas of the pharmaceutical industry, some of the newest and brightest talents are now focusing on cell and…

Continue Reading A Brief Discussion of How Cell and Gene Therapies are Being Improved for Future Generations

Research Team Identifies Diagnostic Errors in Three Classes of Disease Associated with a High Death Rate or Permanent Disability

  The number of people in the U.S. who are permanently disabled or who die each year as a result of misdiagnosis is estimated to be over 100,000. EurekAlert recently reported…

Continue Reading Research Team Identifies Diagnostic Errors in Three Classes of Disease Associated with a High Death Rate or Permanent Disability

Watch: New York Giants Running Back Grants Wish for Teen Living with Ewing’s Sarcoma

15-year-old George Taylor reached out to NY Giants Running Back Saquon Barkley, telling the star NFL player how he's an inspiration to him for when he undergoes his chemotherapy for Ewing's sarcoma,…

Continue Reading Watch: New York Giants Running Back Grants Wish for Teen Living with Ewing’s Sarcoma
Biotech Companies Team Up to Launch MapKure, a New Joint Venture to Develop Small Molecule Anticancer Drug
rawpixel / Pixabay

Biotech Companies Team Up to Launch MapKure, a New Joint Venture to Develop Small Molecule Anticancer Drug

According to a press release from BeiGene, the Company and SpringWorks Therapeutics have launched MapKure, LLC — a new, jointly-operated venture owned by both partners. MapKure was founded to develop…

Continue Reading Biotech Companies Team Up to Launch MapKure, a New Joint Venture to Develop Small Molecule Anticancer Drug